REFERENCES
- Borgna-Pignatti C, Rugolotto S, De Stefano P, et al. Survival and complications in patients with thalassemia major treated with transfusion and desferrioxamine. Haematologica. 2004;89:1187–1193.
- Aessopos A, Berdoukas V, Tsironi M. The heart in transfusion dependent homozygous thalassaemia today–prediction, prevention and management. Eur J Haematol. 2008;80(2):93–106.
- Tanner MA, Galanello R, Dessi C, et al. Myocardial iron loading in patients with thalassemia major on desferrioxamine chelation. J Cardiovasc Magn Reson. 2006;8:543–547.
- Berdoukas V, Dakin C, Freema A, Fraser I, Aessopos A, Bohane T. Lack of correlation between iron overload cardiac dysfunction and needle liver biopsy iron concentration. Haematologica. 2005;90(5):685–686.
- Nemeth E, Ganz T. Hepcidin and iron-loading anemias. Haematologica. 2006;91:727–732.
- Oudit GY. Role of L-type Ca2+ channels in iron transport and iron-overload cardiomyopathy. J Mol Med. 2006;84:349–364. Epub 2006 Apr 8.
- Glickstein H. Action of chelators in iron-loaded cardiac cells: accessibility to intracellular labile iron and functional consequences. Blood. 2006;108:3195–3203.
- Telfer PT, Prestcott E, Holden S, Walker M, Hoffbrand AV, Wonke B. Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major. Br J Haematol. 2000;110:971–977.
- Tanner MA, Galanello R, Dessi C, et al. Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction. J Cardiovasc Magn Reson. 2008;10(1):12.
- Anderson LJ, Westwood MA, Holden S, et al. Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous deseferrioxamine: a prospective study using T2* cardiovascular magnetic resonance. Br J Haematol. 2004;127:348–355.
- Aessopos A, Farmakis D, Polonifi A, et al. Plasma B-type natriuretic peptide concentration in beta-thalassaemia patients. Eur J Heart Fail. 2007;9:537–541.
- Aessopos A, Fragodimitri C, Karabatsos F, et al. Cardiac magnetic resonance imaging R2* assessments and analysis of historical parameters in patients with transfusion-dependent thalassemia. Haematologica. 2007;92(1):131–132.
- Aessopos A, Kati M, Tsironi M. Congestive heart failure and treatment in thalassemia major. Hemoglobin. 2008;32(1–2):63–73.